
EIDB is accelerating the Army’s efforts to develop a safe and effective vaccine to prevent infection with COVID-19. The leading vaccine candidate is built on a Spike Ferritin Nanoparticle (SpFN) platform and entered Phase 1 clinical testing in April 2021.